Home › NDC Lookup › Ingredients › Arnica Montana › 53499-3571-02
Arnica Montana 30 [hp_C]/1 Tablet, Bottle of 100 — NDC 53499-3571-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

NDC 53499-3571-02: Arnica Montana 30 [hp_C]/1 Tablet, Bottle of 100

by Schwabe North America, Inc.

This is a package of 100 tablets of Arnica Montana 30 [hp_C]/1 Tablet from Schwabe North America, Inc., first listed with the FDA Jan 2006 and currently FDA-listed, this package's marketing is listed to end Mar 2027. It is the main listing for this product, which comes in 2 package sizes.

🏷️ FDA NDC (as labeled) 53499-3571-2 billing pads the package segment with a zero
This package
Contains100-count Pack sizes2 compare ↓
Main listing for product 53499-3571 · Also comes in: 250 tablets 53499-3571-3
OTC FDA-listed Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Nov 19, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 53499-3571-2 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
53499 labeler · 3571 product · 2 package
Package marketed since
Jan 1, 2006
Package marketing ended
Mar 31, 2027
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 5349935712 5
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 53499-3571-2
Product NDC 53499-3571
11-digit billing NDC 53499357102
UNII O80TY208ZW
SPL Set ID d96936e2-7356-4404-9617-8c61c87fb5d9
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status FDA-listed
FDA listing status Listed (active directory)
Marketing start 2006-01-01
Marketing end 2027-03-31
Route SUBLINGUAL
Dosage form TABLET
Substance ARNICA MONTANA
Why two NDCs? The FDA registers this code as 53499-3571-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 53499-3571-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is a homeopathic tablet taken under the tongue that contains arnica montana. In homeopathic practice, arnica montana is traditionally used to address minor bruising, muscle soreness, and swelling. Homeopathic products are marketed based on traditional use and are not evaluated by the FDA for effectiveness. This product is unapproved by the FDA.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 250 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
53499-3571-02 You're viewing this Main listing 100 TABLET in 1 BOTTLE, GLASS 2006-01-01 Mar 31, 2027 Active
53499-3571-03 53499-3571-3 250 TABLET in 1 BOTTLE, GLASS 2006-01-01 Mar 31, 2027 Active

You're viewing the smallest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 tablet in 1 bottle, glass.
How does this package differ from NDC 53499-3571-03?
Both are Arnica Montana 30 [hp_C]/1 Tablet — the drug itself is identical. This page's package is the 100-count one, while NDC 53499-3571-03 is the 250 tablets package.
What NDC number is used to bill for this package of Arnica Montana 30 [hp_C]/1 Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Arnica Montana 30 [hp_C]this 53499-3571-02 Schwabe 100 tablets — — FDA listed —
Arnica Montana 30C 30 [hp_C] 61727-0111-10 Homeocare 100 tablets — — FDA listed —
Arnica 30C 30 [hp_C] 76472-1129-01 SEVENE 80 pellets — — FDA listed —
Arnica Montana 30C - 3-Pack 30 [hp_C] 76472-5000-02 SEVENE 3 cylinders — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2006
Listed with the FDA since
Jan 2006
📍
2026
Currently FDA-listed
20 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeRound
ImprintB;T
Size6 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.

4 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesCELLULOSE LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM CROSCARMELLOSE 

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSchwabe North America, Inc.
Labeler code53499
First marketedJan 2006
Product typeHuman Otc Drug
Portfolio27 products on file

More NDCs from Schwabe North America, Inc. labeler code 53499

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 19 words ▾

Indications and Usage Temporarily relieves minor muscle or joint aches and pains from strains, sprains, bruises, backache, over extertion.

⏱️ Dosage and Administration 63 words ▾

Dosage and Administration Adults or children over 2 years: Take 3 tablets 1 to 3 times per day. Allow to dissolve under tongue. Indications and Usage Temporarily relieves minor muscle or joint aches and pains from strains, sprains, bruises, backache, over extertion. Purpose For the temporary relief of minor muscle or joint aches and pains from strains, sprains, bruises, backache and over exertion.

⚠️ Warnings 23 words ▾

Warnings Do not use this product for pain for more than 10 days (adult) or 5 days (children) unless directed by a doctor.

🆘 Overdosage 15 words ▾

Overdose In case of overdose, seek medical help or contact a Posion Control Center immediately.

🧪 Active Ingredient 14 words ▾

Active Ingredient Arnica Montana 30C Inactive Ingredients CELLULOSE LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM CROSCARMELLOSE

🧪 Inactive Ingredients 9 words ▾

Inactive Ingredients CELLULOSE LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM CROSCARMELLOSE

🎯 Purpose 21 words ▾

Purpose For the temporary relief of minor muscle or joint aches and pains from strains, sprains, bruises, backache and over exertion.

📄 When Using This Product 35 words ▾

When using When using this product, if pain persists or gets worse, if new symptoms occur, or if redness or swelling is present, consult a doctor because these could be signs of a serous condition.

🤰 If Pregnant or Breast-Feeding 16 words ▾

Pregnancy or Breast Feeding If you are pregnant or breast-feeding, ask a healthcare professional before use.

📄 Keep Out of Reach of Children 12 words ▾

Keep out of reach of children Keep out of reach of children

📄 Package Label / Principal Display Panel 2 words ▾

21203574_Arnica montana-30C_05.jpg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for ARNICA MONTANA — the ingredient across all brands.

Top reported reactions

Fatigue663
Nausea517
Diarrhoea507
Headache490
Pain451
Dizziness450
Arthralgia390

Age at onset

Neonate1
Infant2
Child1
Adolescent4
Adult220
Elderly283

Reporter sex

7,017 reports
Male · 28%
Female · 72%
Unknown · 0%

Serious outcomes

Hospitalization1,547
Disabling639
Life-threatening296
Death255
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 804 238
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Arnica Montana 30 [hp_C]/1 TABLET is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Schwabe North America, Inc. has reported a marketing end date of 2027-03-31, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 250 tablets (53499-3571-03). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Schwabe North America, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.